Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Clinical trial NCT00256932 · COMPLETED
Trial details
- NCT number
- NCT00256932
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Enrollment
- 518
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.